Global Molecular Diagnostics Marketplace Analyzed in New VPG Report Published at Marketpublishers.com

London, UK (PRWEB) September 21, 2012

Besides offering unique advantages, new molecular and genetic diagnostic tests also bring a tidal wave of complexity, cost, and quality issues for health plans. Given the magnitude of these challenges, molecular diagnosticс testing could be one of the biggest game changers health care has witnessed in decades.

New market research report “Analysis of Emerging Molecular Diagnostics Tests and Strategic Profiles of Leading Suppliers” developed by Venture Planning Group (VPG) has been recently published by Market Publishers Ltd.

Report Details:

Title: Analysis of Emerging Molecular Diagnostics Tests and Strategic Profiles of Leading Suppliers
Published: September, 2012
Pages: 548
Price: US$ 4,750.00
http://marketpublishers.com/report/medicine_pharmaceuticals_biotechnology/healthcare_equipment_services/analysis-of-emerging-molecular-diagnostics-tests-n-strategic-profiles-of-leading-suppliers.html

The research report sheds light on the clinical significance and market needs for major current & emerging tests, besides offering extensive listings of 42 companies developing and marketing molecular diagnostic technologies and products.

The strategic assessment of current & emerging suppliers of molecular diagnostic products is carried out through their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.

Report Contents:

Microbiology/Infectious Diseases

a. Overview
b. Major Infectious Diseases
AIDS
     Structure and Composition
     Classification
     AIDS Origins
     Animal Lentivirus Systems
     Virus Receptors
     HIV Infections in Humans
    Pathogenesis and Pathology
     CD4T Lymphocytes and Memory Cells
     Monocytes and Macrophages
     Lymphoid Organs
     Neural Cells
     Viral Coinfections
    Clinical Findings
     Plasma Viral Load
     Pediatric AIDS
    Neurologic Disease
    Opportunistic Infections
    Cancer
     Immunity
    Virus Isolation
    Serology
    Viral Nucleic Acid/Antigen Detection
     Epidemiology
    Worldwide Spread of AIDS
    United States
    Routes of Transmission
     DNA Probes
    Overview
    Quantitative PCR
    In Situ PCR
    Needed Improvements
     Viral Load/Drug Resistance Testing
     Genotype and Phenotype Testing
     Blood Banking Considerations
     Adenovirus
     Background
     Diagnostic Tests
     Vaccines and Drugs
     Adeno-Associated Viruses (AAV)
     Anthrax/Bacillus Anthracis
     Background
     Diagnostic Tests
     Vaccines and Drugs
     Babesiosis
     Background
     BEA and Other Bartonella Diseases
     Background
     Diagnostic Tests
     Vaccines and Drugs
     Chagas Disease
     Background
     Campylobacter
     Background
     Diagnostic Tests
    Culture Identification
     Vaccines and Drugs
     Chlamydia
     Background
    Chlamydia psittaci
    Chlmaydia pneumoniae
    Chlamydia trachomatis
     Diagnostic Tests
     Vaccines and Drugs
     Creutzfeldt-Jakob’s Disease
     Background
     Blood Transmission
     Diagnostic Tests
     Major Commercial and Academic Players
    Bayer
    Disease Sciences/Bi-Tec Global
    Imperial College School of Medicine
    Ortho-Clinical Diagnostics
    Pall
    ProMetic Life Sciences
    Proteome Sciences/Idexx
    Q-One Biotech
    Serono
    U.S. Agricultural Research Service
     Drugs
     Vaccines
     Cytomegalovirus
     Background
    Chorioretinitis
    Gastrointestinal
    Central Nervous System Disease
     Diagnostic Tests
     Vaccines and Drugs
     Ebola Virus
     Background
    Epidemiology
    Clinical Syndromes
     Diagnostic Tests
     Vaccines and Drugs
     EchoVirus
     Background
    Acute Aseptic Meningitisis
    Encephalitis
    Exanthems
...

More new market research reports by the publisher can be found at VPG page.

PDF Print